Current role
Padmanabh P. Bhatt
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Supernus Pharmaceuticals, Inc. (SUPN)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Supernus Pharmaceuticals, Inc. (SUPN) | Senior Vice President, Intellectual Property, Chief Scientific Officer | $455,900 | $1,391,429 |
| 2024 | Supernus Pharmaceuticals, Inc. (SUPN) | Senior Vice President, Intellectual Property, Chief Scientific Officer | $441,034 | $1,552,229 |
| 2023 | Supernus Pharmaceuticals, Inc. (SUPN) | Senior Vice President, Intellectual Property, Chief Scientific Officer | $427,700 | $1,468,211 |
| 2022 | Supernus Pharmaceuticals, Inc. (SUPN) | Senior Vice President, Intellectual Property, Chief Scientific Officer | $415,200 | $1,120,759 |
| 2021 | Supernus Pharmaceuticals, Inc. (SUPN) | Senior Vice President, Intellectual Property, Chief Scientific Officer | $403,100 | $933,265 |
| 2020 | Supernus Pharmaceuticals, Inc. (SUPN) | Senior Vice President, Intellectual Property, Chief Scientific Officer | $391,401 | $1,074,490 |
| 2019 | Supernus Pharmaceuticals, Inc. (SUPN) | Senior Vice President, Intellectual Property, Chief Scientific Officer | $380,018 | $1,311,587 |
| 2018 | Supernus Pharmaceuticals, Inc. (SUPN) | Senior Vice President, Intellectual Property, Chief Scientific Officer | $369,000 | $1,229,803 |
| 2017 | Supernus Pharmaceuticals, Inc. (SUPN) | Senior Vice President, Intellectual Property, Chief Scientific Officer | $358,000 | $1,063,281 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.